- funded by IMI-JU
- 01 March 2011 - 31 August 2016
- 11 EFPIA members
- 10 Academia and 5 SME's
- Total cost € 23,032,609
The Modeling & Simulation department at Novartis Pharma AG supports the optimal development of therapeutic drugs through the application of mathematical models. We integrate the principles of biology, pharmacology, and statistics in order to explain and to predict the quantitative consequences of decisions.
Novartis M&S has very strong experience in model development, development of computational tools for simulation and analysis, and the application of models and their simulation across the complete drug discovery and development process.